Literature DB >> 25505294

The effects of cytokines on spontaneous hepatitis B surface antigen seroconversion in chronic hepatitis B virus infection.

Jia-Feng Wu1, Hong-Yuan Hsu1, Yu-Chun Chiu1, Huey-Ling Chen2, Yen-Hsuan Ni3, Mei-Hwei Chang4.   

Abstract

We examined the role of human cytokines in the natural course of hepatitis B surface Ag (HBsAg) seroconversion in chronic hepatitis B virus (HBV) infection. The clinical course of spontaneous HBsAg seroconversion was assessed in 296 chronically HBV-infected patients. Single nucleotide polymorphisms (SNPs) in IL-1β, IL-2, IL-4, IL-10, IL-12β, IL-13, IL-27, and IFN-γ genes were examined in 296 chronically HBV-infected patients and another 193 HBV recoverers. The HBsAg a determinant sequence of chronically HBV-infected subjects with and without HBsAg seroconversion was also analyzed. The start of the immune-clearance phase (serum alanine aminotransferase levels > 30 IU/l) before the age of 48 mo and hepatitis B e Ag (HBeAg) seroconversion before the age of 10 y predicted spontaneous HBsAg seroconversion in chronically HBV-infected patients (odds ratios 17.7 and 5.0; p < 0.001 and p < 0.002, respectively). The A-allele of IL-10 SNP rs1800872 was associated with higher IL-10 serum levels, and the G-allele of IL-12β SNP rs3212217 was associated with sustained high serum IL-12p70 levels during the immune-clearance phase. Both were predictors of spontaneous HBsAg seroconversion and HBV recovery (odds ratios 4.0 and 26.3; p = 0.002 and p < 0.001, respectively). Spontaneous HBsAg seroconversion was not related to sex, HBV genotype, or HBsAg a determinant mutation. The start of immune-clearance phase, age at HBeAg seroconversion, and serum IL-10 and IL-12 levels are associated with the course of the immune-clearance phase in chronic HBV infection, and are predictive of spontaneous HBsAg seroconversion and HBV recovery.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25505294     DOI: 10.4049/jimmunol.1401659

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  T follicular helper cells improve the response of patients with chronic hepatitis B to interferon by promoting HBsAb production.

Authors:  Yong Liu; Xintong Hu; Xiaoli Hu; Lei Yu; Huifan Ji; Wanyu Li; Yanjun Cai; Genhong Cheng; Yanfang Jiang
Journal:  J Gastroenterol       Date:  2022-01-06       Impact factor: 7.527

Review 2.  Crosstalk between innate and adaptive immunity in hepatitis B virus infection.

Authors:  Li Wang; Kai Wang; Zhi-Qiang Zou
Journal:  World J Hepatol       Date:  2015-12-28

3.  Association of IL-10 polymorphisms with hepatitis B virus infection and outcome in Han population.

Authors:  Lei Gao; Xi Chen; Lian Zhang; Di Wu; He Zhao; Junqi Niu
Journal:  Eur J Med Res       Date:  2016-06-01       Impact factor: 2.175

Review 4.  Natural history of chronic hepatitis B virus infection from infancy to adult life - the mechanism of inflammation triggering and long-term impacts.

Authors:  Jia-Feng Wu; Mei-Hwei Chang
Journal:  J Biomed Sci       Date:  2015-10-20       Impact factor: 8.410

5.  Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment.

Authors:  Renyong Guo; Hejun Mao; Xiao Hu; Nengneng Zheng; Dong Yan; Jianqin He; Jiezuan Yang
Journal:  Sci Rep       Date:  2016-11-15       Impact factor: 4.379

Review 6.  Cytokines and Chemokines in HBV Infection.

Authors:  Shihong Zhong; Tianling Zhang; Libo Tang; Yongyin Li
Journal:  Front Mol Biosci       Date:  2021-12-02

Review 7.  Association Between IL-4 Polymorphisms and Risk of Liver Disease: An Updated Meta-Analysis.

Authors:  Zhitong Wu; Wenzhou Qin; Jie Zeng; Chunni Huang; Yu Lu; Shan Li
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.